We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Gilead Sciences Inc | NASDAQ:GILD | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.54 | -0.83% | 64.79 | 64.30 | 64.85 | 65.53 | 64.33 | 65.51 | 7,822,721 | 05:00:04 |
Gilead Sciences, Inc. (GILD) is currently at $66.74, up $3.54 or 5.6%
-- Would be highest close since Dec. 23, 2019, when it closed at $66.75
-- On pace for largest percent increase since Aug. 30, 2017, when it rose 7.25%
-- On Friday, The Wall Street Journal reported that Chinese officials had reached an agreement with Gilead to test remdesivir in patients with coronavirus. The same day, the New England Journal of Medicine published a case report on a man sickened with the coronavirus in Washington state who was given remdesivir, and whose condition began to improve the following day
-- Snaps a three day losing streak
-- Down 45.39% from its all-time closing high of $122.21 on June 23, 2015
-- Traded as high as $68.68; highest intraday level since July 5, 2019, when it hit $69.34
-- Up 8.67% at today's intraday high; largest intraday percent increase since Nov. 12, 2012, when it rose as much as 14.35%
-- Best performer in the S&P 500 today
-- Third best performer in the Nasdaq 100 today
All data as of 2:58:18 PM
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 03, 2020 15:21 ET (20:21 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Gilead Sciences Chart |
1 Month Gilead Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions